Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869246 | PMC |
| http://dx.doi.org/10.3389/fmicb.2022.1127058 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In Search of the Shot to Kill Cancer: Possibilities and Limitations.
Ann Surg Oncol
December 2024
Department of Surgery, Duke University, Durham, NC, USA.
Perioperative acute kidney injury - cloaked and hidden - know your enemy.
Pol Merkur Lekarski
December 2024
1ST DEPARTMENT OF ANESTHESIOLOGY AND INTENSIVE CARE, INFANT JESUS CLINICAL HOSPITAL UCC MUW, WARSAW, POLAND.
Surgery and anaesthesia come with adverse effects. As obvious as it is, not all of them are considered frequently enough. It may seem reasonable because some of them kill instantly.
View Article and Find Full Text PDFActivation of the immune deficiency pathway (IMD) reduces the mosquito heart rate via a nitric oxide-based mechanism.
J Insect Physiol
December 2024
Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA. Electronic address:
The immune deficiency pathway (IMD) is an important component of the antibacterial, antimalarial and antiviral response in mosquitoes. The IMD pathway also drives the infection induced migration of hemocytes to the heart. During an infection, periostial hemocytes kill pathogens in areas of high hemolymph flow and produce nitric oxide that reduces the heart rate.
View Article and Find Full Text PDFTargeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy.
Front Pharmacol
November 2024
School of Pharmacy and Department of Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
Cancer is a serious public health problem in humans, and prevention and control strategies are still necessary. Therefore, the development of new therapeutic drugs is urgently needed. Targeting programmed cell death, particularly via the induction of cancer cell apoptosis, is one of the cancer treatment approaches employed.
View Article and Find Full Text PDFOncolytic virus and CAR-T cell therapy in solid tumors.
Front Immunol
November 2024
Dipartimento di Medicina e Chirurgia Traslazionali, Sezione di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
Adoptive immunotherapy with T cells, genetically modified to express a tumor-reactive chimeric antigen receptor (CAR), is an innovative and rapidly developing life-saving treatment for cancer patients without other therapeutic opportunities. CAR-T cell therapy has proven effective only in hematological malignancies. However, although by now only a few clinical trials had promising outcomes, we predict that CAR-T therapy will eventually become an established treatment for several solid tumors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!